Healthpeak Properties, Inc. (DOC) stock analysis
Close on Nov 11, 2026Market cap $14.05BP/E 58.2Yield 5.99%
StockData Score
Prices as of Nov 11, 2026How the score works
Weak8 of 30 checks passed
Healthpeak Properties passes 8 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 4/6
- Past performance
- 0/6
- Financial health
- 0/6
- Dividend
- 3/6
What stands out
Revenue growing 10%+ a year
Revenue grew 11.0% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 47.5% over the last twelve months, against a 5-year average of -29.6% a year.
Guidance raised
Healthpeak Properties raised its Full Year 2026 Total Same-Store Cash (Adjusted) NOI outlook on Aug 4, 2026.
EV/EBITDA below its 5-year median
Healthpeak Properties's EV/EBITDA of 7.5 is below its 5-year median of 8.7.
What to watch
Margin of safety under 20%
The price is 20.9% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $20.38 is above our fair value estimate of $16.85.
Return on equity under 15%
Return on equity was 3.1% over the last twelve months and averaged 4.8% over five years; we look for 15% on both.
Earnings shrank over 5 years
Net income shrank 29.6% a year on average over the last five fiscal years.
Valuation1/6
P/E above its 5-year median
Healthpeak Properties's P/E of 58.2 is above its own 5-year median of 43.7.
P/E above the industry
Healthpeak Properties's P/E of 58.2 is above the Miscellaneous Investing median of 26.3.
EV/EBITDA below its 5-year median
Healthpeak Properties's EV/EBITDA of 7.5 is below its 5-year median of 8.7.
P/B above the industry
Healthpeak Properties's price-to-book of 1.79 is above the Miscellaneous Investing median of 1.20.
Trading above fair value
The share price of $20.38 is above our fair value estimate of $16.85.
Margin of safety under 20%
The price is 20.9% above fair value, so there is no margin of safety.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 11.0% a year over the last three fiscal years.
EPS growing under 10% a year
Diluted EPS grew -52.3% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 47.5% over the last twelve months, against a 5-year average of -29.6% a year.
Growing faster than the industry
Revenue grew 5.5% over the last twelve months; the Miscellaneous Investing median is 4.6%.
Guidance raised
Healthpeak Properties raised its Full Year 2026 Total Same-Store Cash (Adjusted) NOI outlook on Aug 4, 2026.
Gross margin trend
This company does not report gross profit.
Past performance0/6
Return on equity under 15%
Return on equity was 3.1% over the last twelve months and averaged 4.8% over five years; we look for 15% on both.
Return on invested capital
Needs operating income and invested capital.
Return on equity below the industry
Healthpeak Properties's return on equity of 3.1% is below the Miscellaneous Investing median of 3.1%.
Earnings shrank over 5 years
Net income shrank 29.6% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 8.2% over the last twelve months, against a 5-year average of 15.3%.
Net margin below the industry
Healthpeak Properties's net margin of 8.2% is below the Miscellaneous Investing median of 10.3%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Elevated bankruptcy risk
The Altman Z-score is 0.83; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Healthpeak Properties paid dividends worth 6.0% of the share price over the last twelve months.
Yield above Treasuries
The 6.0% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; Healthpeak Properties yields 6.0%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Not covered by earnings
Dividends take 348% of net income, leaving little room.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$16.85
The share price is 21% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 35.1× | 43.7× | 26.3× | $12.29 | 40% |
| EV/EBITDA | 9.1× | 8.7× | 9.5× | $27.17 | 35% |
| P/B | 1.5× | 1.7× | 1.2× | $16.54 | 10% |
| Earnings power | 8.4% cost of equity | – | – | $5.15 | 15% |
| Fair value | $16.85 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 43.7
- Miscellaneous Investing median 26.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $120.49M
- Value traded per 1% price move
- $94.01M
Downside
Low risk
- Typical loss in a bad month
- 10.8%
- Volatility (annualized)
- 29%
- Sharpe ratio, 1 year
- 0.37
- Beta to the S&P 500 (5Y)
- 0.71
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +4.5% | +11.0% | +11.4% | +3.8% | |
| Net income | -70.7% | -47.8% | -29.6% | – | |
| EPS, diluted | -72.2% | -52.3% | -33.5% | – | |
| Free cash flow | +7.0% | – | – | -8.2% | |
| Dividend per share | +1.7% | +0.6% | -3.8% | -6.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.4% | 6.5% | 0.9% | |
| Return on assets | 3.4% | 2.8% | 0.4% | |
| Capex to revenue | 21.6% | 48.0% | 31.7% | |
| Diluted shares | 467M | 531M | 696M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Healthpeak Properties generated $4.97B from operations and spent $8.10B on capital expenditure, dividends and share buybacks. 51% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 2.5% | 0.14× | 2.53× | 0.9% |
| FY2024 | 9.0% | 0.15× | 2.42× | 3.3% |
| FY2023 | 14.0% | 0.14× | 2.42× | 4.7% |
| FY2022 | 24.3% | 0.13× | 2.36× | 7.6% |
| FY2021 | 26.7% | 0.12× | 2.35× | 7.6% |
| FY2020 | 25.1% | 0.11× | 2.34× | 6.5% |
| FY2019 | 3.7% | 0.09× | 2.22× | 0.8% |
| FY2018 | 89.1% | 0.09× | 2.38× | 18.9% |
| FY2017 | 22.4% | 0.12× | 2.75× | 7.6% |
| FY2016 | 29.5% | 0.11× | 2.50× | 8.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$71.35M
- Cash generatingOperating cash flow above zero$1.25B
- Return on assets improvedROA up on the prior year1.5% → 0.4%
- Earnings backed by cashOperating cash flow above net income$1.25B vs $71.35M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise676M → 696M
- Gross margin improvedGross margin up on the prior year60.20% → –
- More efficientAsset turnover rose0.17 → 0.14
See a number that looks wrong?